Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,262.56 89.32 0.55%
S&P 500 1,842.98 12.37 0.68%
NASDAQ 4,034.16 11.47 0.29%
Ticker Volume Price Price Delta
STOXX 50 3,124.54 33.02 1.07%
FTSE 100 6,570.88 29.27 0.45%
DAX 9,263.63 89.92 0.98%
Ticker Volume Price Price Delta
NIKKEI 14,417.68 420.87 3.01%
TOPIX 1,166.55 30.46 2.68%
HANG SENG 22,696.01 24.75 0.11%

Orion Oyj : Listing prospectus for Orion Corporation's EUR 150 million bond available



 Orion Oyj : Listing prospectus for Orion Corporation's EUR 150 million bond
                                  available

 
 

ORION CORPORATION        STOCK EXCHANGE RELEASE 11 JUNE 2013 at 2.00 p.m. EEST
             

  
On 4 June 2013, Orion Corporation announced that it had resolved to issue a
EUR 150 million fixed rate unsecured bond with a maturity of six (6) years.

The Finnish Financial Supervisory Authority has approved the listing
prospectus of the bond today. The prospectus is available on Orion
Corporation's website http://www.orion.fi/en/investors.

The Company has submitted an application to NASDAQ OMX Helsinki Ltd to apply
for the listing of the bond. The bond is expected to be admitted to public
trading on or about 12 June 2013.

  
Orion Corporation

Timo Lappalainen   Jari Karlson
President and CEO  CFO

                       
     
  

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Homepage: www.orion.fi

Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical
ingredients and diagnostic tests. The company is continuously developing new
drugs and treatment methods. Pharmaceutical R&D focuses on central nervous
system drugs, oncology and critical care drugs, and Easyhaler® pulmonary
drugs.

Orion's net sales in 2012 amounted to EUR 980 million and the company had
about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX
Helsinki.

Disclaimer

The information contained  in this release  shall not constitute  an offer  to 
sell securities of Orion Corporation in any jurisdiction. In particular,  this 
release does not constitute an offer to sell securities in the United  States. 
Any securities referred to herein have  not been, and will not be,  registered 
under the U.S. Securities  Act of 1933,  as amended, and  may not be  offered, 
exercised or sold in  the United States absent  registration or an  applicable 
exemption from registration requirements.

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: Orion Oyj via Thomson Reuters ONE
HUG#1708328
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement